Disease modifying treatment in relapsing-remitting MS, proportion (%) - Target level ≥ 90
Description
Percentage of people under 40 years of age with relapsing-remitting MS receiving disease-modifying treatment. Disease-modifying treatments in MS aim to inhibit and limit the spread of inflammation in the central nervous system. Relapsing-remitting MS is characterized by the person experiencing periods of deterioration, so-called relapses.
Resources
| Name |
Format |
Description |
Link |
|
0 |
|
http://data.europa.eu/88u/dataset/http-api-kolada-se-v2-kpi-u70511 |
Tags
- rådet-för-främjande-av-kommunala-analyser-kolada
- region